text: "The subdermal implant proposed by Iaso Biodelivery to treat the AD is being developed to release controlled doses of drug over an extended period of time. The use of this technology is focused on increasing patient compliance to the treatment, resulting in greater control over the progression of the disease."
name: "Solution"
# FIXME Centralizar
# position: "CEO, TransTech"
avatar: "img/testimonials/produto-3.jpg"
